Ocular Therapeutix, Inc.
NASDAQ:OCUL
8.43 (USD) • At close July 26, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ocular Therapeutix, Inc. |
Symbool | OCUL |
Munteenheid | USD |
Prijs | 8.43 |
Beurswaarde | 1,305,714,270 |
Dividendpercentage | 0% |
52-weken bereik | 1.995 - 11.31 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Antony Mattessich |
Website | https://www.ocutx.com |
An error occurred while fetching data.
Over Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)